MAVU-104

N/A

Report date: 2025/01/26 19:03:32

NME

Base Information

Drug NameMAVU-104

Drug Alias NameENPP1 small molecule inhibitor (Mavupharma)STING agonist (Mavupharma)stimulator of interferon genes pathway modulators (Mavupharma)MAVU-104

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionEctonucleotide Pyrophosphatase/Phosphodiesterase 1 inhibitorsStimulator of interferon genes stimulants

TargetsEctonucleotide Pyrophosphatase/Phosphodiesterase 1Stimulator of interferon genes

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesMavupharma Inc

China Registration ClassN/A

Develop Information

Active CompaniesMavupharma Inc

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A